Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

A hybrid clinical and electrocardiographic score to predict the origin of outflow tract ventricular arrhythmias.

PMID: 36795268
Journal: JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
Year: 2023
Reference: J Interv Card Electrophysiol. 2023 Feb 16. doi: 10.1007/s10840-023-01507-x.
Impact factor:
Publication type: Paper in international publication
Authors: Acosta, Juan; Alderete, Jose; Ali, Hussam; Bellido, Aldo; Benito, Begona; Berruezo, Antonio; Camara, Oscar; Cappato, Riccardo; Carreno, Jose Miguel; Chauca, Alfredo et al.
DOI: 10.1007/s10840-023-01507-x

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

PMID: 37116492
Journal: CANCER CELL
Year: 2023
Reference: Cancer Cell. 2023 Apr 24:S1535-6108(23)00128-9. doi: 10.1016/j.ccell.2023.04.002.
Impact factor:
Publication type: Paper in international publication
Authors: Almekinders, Mathilde M; Badoux, Madelon; Behbod, Fariba; Chao, Xue; Ciwinska, Marta; Davies, Helen R; de Bruijn, Roebi; Eijkman, Timo; Herencia-Ropero, Andrea; Herencia-Ropero, Andrea et al.
DOI: 10.1016/j.ccell.2023.04.002

A longitudinal and multidesign epidemiological study to analyze the effect of the volcanic eruption of Tajogaite volcano (La Palma, Canary Islands). The ASHES study protocol.

PMID: 36206927
Journal: ENVIRONMENTAL RESEARCH
Year: 2023
Reference: Environ Res. 2023 Jan 1;216(Pt 2):114486. doi: 10.1016/j.envres.2022.114486. Epub 2022 Oct 4.
Impact factor:
Publication type: Paper in international publication
Authors: Acosta, Orlando; Barreiro, Esther; Canas, Ana; Candal-Pedreira, Cristina; Casanova, Ciro; Castano, Argelia; Cruz Carmona, Maria Jesus; Diaz Perez, David; Diego, Carmen; Garcia-Aymerich, Judith et al.
DOI: 10.1016/j.envres.2022.114486

A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.

PMID: 37942762
Journal: HEMATOLOGICAL ONCOLOGY
Year: 2023
Reference: Hematol Oncol. 2023 Nov 9. doi: 10.1002/hon.3235.
Impact factor:
Publication type: Paper in international publication
Authors: Abrisqueta, Pau; Aguade-Bruix, Santiago; Campo, Elias; Casanueva-Eliceiry, Sebastian; Correa, Juan Gonzalo; Delgado, Julio; Ferreira Gonzalez, Ignacio; Gine, Eva; Gomez-Hernando, Marta; Guinetti-Ortiz, Katia et al.
DOI: 10.1002/hon.3235

A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe.

PMID: 37737767
Journal: CYTOTHERAPY
Year: 2023
Reference: Cytotherapy. 2023 Sep 5:S1465-3249(23)01015-0. doi: 10.1016/j.jcyt.2023.08.001.
Impact factor:
Publication type: Review in international publication
Authors: Akker, Emile van den; Baudoux, Etienne; De Vos, John; Delgadillo, Joaquin; Delgadillo, Joaquin; Gardiner, Nicola; Kerkela, Erja; Lechanteur, Chantal; Vives, Joaquim; Waters, Allison et al.
DOI: 10.1016/j.jcyt.2023.08.001

A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.

PMID: 36842942
Journal: European Urology Oncology
Year: 2023
Reference: Eur Urol Oncol. 2023 Jun;6(3):339-348. doi: 10.1016/j.euo.2023.01.012. Epub 2023 Feb 25.
Impact factor:
Publication type: Paper in international publication
Authors: Barata, Pedro C; Betts, Keith A; Blum, Steven I; Bourlon, Maria T; Burotto, Mauricio; Cella, David; Chin, Andi; Choueiri, Toni K; Del Tejo, Viviana; Du, Ella X et al.
DOI: 10.1016/j.euo.2023.01.012

A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER).

PMID: 36380155
Journal: CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
Year: 2023
Reference: Cardiovasc Intervent Radiol. 2023 Feb;46(2):259-267. doi: 10.1007/s00270-022-03309-6. Epub 2022 Nov 15.
Impact factor:
Publication type: Paper in international publication
Authors: Lenton, James; Littler, Peter; Pech, Maciej; Planert, Mathis; Serres, Xavier; Smith, Jonathan; Solbiati, Luigi; Stenberg, Benjamin; Thormann, Maximilian; Torzilli, Guido et al.
DOI: 10.1007/s00270-022-03309-6

A multistrain probiotic increases the serum glutamine/glutamate ratio in patients with cirrhosis: a metabolomic analysis.

PMID: 37026745
Journal: Hepatology Communications
Year: 2023
Reference: Hepatol Commun. 2023 Apr 4;7(4):e0072. doi: 10.1097/HC9.0000000000000072. eCollection 2023 Apr 1.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarado, Edilmar; Canalda-Baltrons, Aleix; Claria, Joan; Cuyas, Berta; Escorsell, Angels; Guarner, Carlos; Laghi, Luca; Lan, Qiuyu; Manichanh, Chaysavanh; Nieto, Juan Camilo et al.
DOI: 10.1097/HC9.0000000000000072

A multi-trait genetic Study of Hemostatic factors and Hemorrhagic transformation after stroke treatment.

PMID: 38103737
Journal: Journal of thrombosis and haemostasis : JTH
Year: 2023
Reference: J Thromb Haemost. 2023 Dec 14:S1538-7836(23)00870-X. doi: 10.1016/j.jtha.2023.11.027.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Sabin, Jose; Amaya Pascasio, Laura; Arenillas, Juan F; Arjona Padillo, Antonio; Blanco Madera, Sara; Blanco Ruiz, Marina; Carcel-Marquez, Jara; Carneado-Ruiz, Joaquin; Castellanos, Maria Del Mar; Castillo, Jose et al.
DOI: 10.1016/j.jtha.2023.11.027

A new era for Advances in Laboratory Medicine.

PMID: 38075176
Journal: Advances in Laboratory Medicine
Year: 2023
Reference: Adv Lab Med. 2023 Sep 13;4(3):203-204. doi: 10.1515/almed-2023-0116. eCollection 2023 Sep.
Impact factor:
Publication type: Editorail in international publication
Authors: Arribas, Ignacio; Azpiroz, Fernando; Fernandez-Calle, Pilar; Ferrer-Costa, Roser; Gonzalez, Alvaro; Jimenez, Wladimiro; Livovsky, Dan M; Nieto, Adoracion et al.
DOI: 10.1515/almed-2023-0116

A new set of in silico tools to support the interpretation of ATM missense variants using graphical analysis.

PMID: 37865290
Journal: JOURNAL OF MOLECULAR DIAGNOSTICS
Year: 2023
Reference: J Mol Diagn. 2023 Oct 19:S1525-1578(23)00243-X. doi: 10.1016/j.jmoldx.2023.09.009.
Impact factor:
Publication type: Paper in international publication
Authors: Blanco, Ana; Brandsma, D; Cruz, Xavier de la; Curigliano, G; Diez, Orland; Feliubadalo, Lidia; Furtner, J; Gutierrez-Enriquez, Sara; Hoya, Miguel de la; Lazaro, Conxi et al.
DOI: 10.1016/j.jmoldx.2023.09.009

A PET-CT score for discriminating malignant from benign pleural effusions.

PMID: 37487808
Journal: MEDICINA CLINICA
Year: 2023
Reference: Med Clin (Barc). 2023 Jul 22:S0025-7753(23)00368-8. doi: 10.1016/j.medcli.2023.06.011.
Impact factor:
Publication type: Paper in national publication
Authors: Aleman, Carmen; Montoro, Bruno; Persiva, Oscar; Sanchez, Leire; Sanchez, Leire; Sansano, Irene; Simo, Marc; Vazquez, Ana et al.
DOI: 10.1016/j.medcli.2023.06.011

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumors.

PMID: 36579743
Journal: JOURNAL OF CLINICAL PHARMACOLOGY
Year: 2023
Reference: J Clin Pharmacol. 2023 May;63(5):583-592. doi: 10.1002/jcph.2198. Epub 2023 Jan 27.
Impact factor:
Publication type: Paper in international publication
Authors: D'Arcangelo, Manolo; Felip, Enriqueta; Garrido, Pilar; Gupta, Neeraj; Hanley, Michael J; Vranceanu, Florin; Ye, Meng; Zhu, Jiaxi et al.
DOI: 10.1002/jcph.2198

A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors.

PMID: 37292376
Journal: Frontiers in Pediatrics
Year: 2023
Reference: Front Pediatr. 2023 May 24;11:1183295. doi: 10.3389/fped.2023.1183295. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Aerts, Isabelle; Andre, Nicolas; Bautista, Francisco; Croop, James M; De Wilde, Bram; Gerber, Nicolas U; Gros Subias, Luis; Hamidi, Ali; Kunduri, Srinivasa; Lawrence, Tatiana et al.
DOI: 10.3389/fped.2023.1183295

A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.

PMID: 36251503
Journal: HEMATOLOGICAL ONCOLOGY
Year: 2023
Reference: Hematol Oncol. 2023 Feb;41(1):108-119. doi: 10.1002/hon.3089. Epub 2022 Oct 31.
Impact factor:
Publication type: Paper in international publication
Authors: Abbadessa, Giovanni; Alves, Daniela; Araujo, Luis; Bouabdallah, Krimo; Carlo-Stella, Carmelo; Carpio, Cecilia; Cartron, Guillaume; Casasnovas, Olivier; Chamuleau, Martine; Cordoba, Raul et al.
DOI: 10.1002/hon.3089

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.

PMID: 37712875
Journal: Cancer research communications
Year: 2023
Reference: Cancer Res Commun. 2023 Sep 14;3(9):1853-1861. doi: 10.1158/2767-9764.CRC-23-0333.
Impact factor:
Publication type: Paper in international publication
Authors: Ahn, Myung-Ju; Bauer, Michael; Beni, Laura; Bobadilla, Maria; Cortes, Javier; Cortes, Javier; DeAngelo, Daniel; Garralda, Elena; Hanna, Glenn J; Hess, Dagmar et al.
DOI: 10.1158/2767-9764.CRC-23-0333

A phase Ib study of the DNA-PK inhibitor peposertib combined with neoadjuvant chemoradiation in patients with locally advanced rectal cancer.

PMID: 38051750
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Dec 5. doi: 10.1158/1078-0432.CCR-23-1129.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, Eduardo J; Amoretti, Silvia; Becker, Andreas; Bernardo, Miquel; Berrocoso, Esther; Capdevila, Jaume; Coenen-Stass, Anna; Cuesta, Manuel J; Escarti, Maria J; Fernandez-Martos, Carlos et al.
DOI: 10.1158/1078-0432.CCR-23-1129

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.

PMID: 36811382
Journal: ONCOLOGIST
Year: 2023
Reference: Oncologist. 2023 Feb 22:oyad007. doi: 10.1093/oncolo/oyad007.
Impact factor:
Publication type: Paper in international publication
Authors: De Braud, Filippo; de Miguel, Maria J; Edwards, Michelle; Elez, Elena; Fiorella Dotti, Katia; Garralda, Elena; Geva, Ravit; Litwiler, Kevin; Morris, Van Karlyle; Murphy, Danielle et al.
DOI: 10.1093/oncolo/oyad007

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study.

PMID: 36083313
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY
Year: 2023
Reference: Cancer Immunol Immunother. 2023 Apr;72(4):827-840. doi: 10.1007/s00262-022-03283-5. Epub 2022 Sep 9.
Impact factor:
Publication type: Paper in international publication
Authors: Ayuso, Juan Ramon; Benitez-Ribas, Daniel; Cabezon, Raquel; Cascante, Marta; Cid, Joan; Cuatrecasas, Miriam; Elez, Elena; Espanol-Rego, Marta; Fernandez-Martos, Carlos; Foguet, Carles et al.
DOI: 10.1007/s00262-022-03283-5

A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2-) Advanced or Metastatic Breast Cancer.

PMID: 37992310
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Nov 22. doi: 10.1158/1078-0432.CCR-23-0133.
Impact factor:
Publication type: Paper in international publication
Authors: Abdel-Mannan, Omar; Barbash, Olena; Cescon, David W; Champsas, Dimitrios; Chitre, Manali; Ciccarelli, Olga; Desai, Ishita; Dhar, Arindam; Forsyth, Rob; Hacohen, Yael et al.
DOI: 10.1158/1078-0432.CCR-23-0133

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.

PMID: 36378548
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Jan 17;29(2):331-340. doi: 10.1158/1078-0432.CCR-22-2074.
Impact factor:
Publication type: Paper in international publication
Authors: Anthoney, Alan; Arkenau, Tobias; Banerji, Udai; Blagden, Sarah; Carter, Louise; Garralda, Elena; Jones, Robert; Klencke, Barbara J; Kowalski, Mark M; Kristeleit, Rebecca et al.
DOI: 10.1158/1078-0432.CCR-22-2074

A plain language summary of what clinical studies can tell us about the safety of evobrutinib - a potential treatment for multiple sclerosis.

PMID: 37345645
Journal: Neurodegenerative disease management
Year: 2023
Reference: Neurodegener Dis Manag. 2023 Jun 22. doi: 10.2217/nmt-2023-0003.
Impact factor:
Publication type: Review in international publication
Authors: Bolay, Claire Le; Genovese, Mark C; Guehring, Hans; Kao, Amy H; Montalban, Xavier; Parsons-Rich, Dana; Tomic, Davorka; Wallace, Daniel et al.
DOI: 10.2217/nmt-2023-0003

A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.

PMID: 37369988
Journal: PEDIATRIC BLOOD & CANCER
Year: 2023
Reference: Pediatr Blood Cancer. 2023 Jun 27:e30506. doi: 10.1002/pbc.30506.
Impact factor:
Publication type: Paper in international publication
Authors: Daugherty, Claire; Gallardo, Eva; Gros, Luis; Hill, Christon; Janeway, Katherine A; Rizzari, Carmelo; Schwartz, Stefan; Thomas, Emma; Ward, Suzanne et al.
DOI: 10.1002/pbc.30506

A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies - an EAACI Position paper.

PMID: 36176045
Journal: ALLERGY
Year: 2023
Reference: Allergy. 2023 Jan;78(1):20-46. doi: 10.1111/all.15533. Epub 2022 Oct 18.
Impact factor:
Publication type: Paper in international publication
Authors: Alviani, Cherry; Angier, Elizabeth; Blumchen, Katharina; Comberiati, Pasquale; Duca, Bettina; DunnGalvin, Audrey; Egmose, Britt; Garriga-Baraut, Teresa; Gore, Claudia; Gowland, M Hazel et al.
DOI: 10.1111/all.15533

Publications